Brick & Kyle Associates’s Sanofi SNY Stock Holding History

Brick & Kyle Associates’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-370	Closed	-$17K	–	320
2017 Q1	$17K	Hold	370	–	–	0.01%	300
2016 Q4	$15K	Hold	370	–	–	0.01%	316
2016 Q3	$14K	Hold	370	–	–	0.01%	318
2016 Q2	$15K	Hold	370	–	–	0.01%	308
2016 Q1	$15K	Hold	370	–	–	0.01%	295
2015 Q4	$16K	Hold	370	–	–	0.01%	290
2015 Q3	$18K	Buy	+370	New	+$18.8K	0.02%	275
2015 Q2	–	Sell	-100	Closed	-$5K	–	460
2015 Q1	$5K	Hold	100	–	–	﹤0.01%	415
2014 Q4	$5K	Buy	+100	New	+$4.85K	﹤0.01%	393

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brick & Kyle Associates's SNY Position: Q2 2017 in Review

Brick & Kyle Associates sold out of Sanofi (SNY) in Q2 2017, closing a stake of 370 shares — an estimated $17K sold.

Brick & Kyle Associates first reported a position in SNY in Q4 2014 and held it in 9 quarters. The position peaked at $18K in Q3 2015. 475 funds tracked by Wall St. Rank hold SNY as of Q2 2017.

Brick & Kyle Associates reported no remaining Sanofi position as of Q2 2017 after selling out during the quarter.
Brick & Kyle Associates sold 370 Sanofi shares in Q2 2017, an estimated $17K.
Brick & Kyle Associates first reported a position in Sanofi in Q4 2014 and held it in 9 quarters.
Brick & Kyle Associates's Sanofi position peaked at $18K in Q3 2015.
475 funds tracked by Wall St. Rank held Sanofi as of Q2 2017.

Based on Brick & Kyle Associates's 13F filing for Q2 2017, filed 14 Aug 2017.